XM tidak memberikan layanan kepada penduduk Amerika Serikat.
W
W

Walgreens


Berita

Baltimore to take drug distributors to trial over opioids

UPDATE 1-Baltimore to take drug distributors to trial over opioids Adds comment from Cencora in paragraph 4 By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.
T
W
M

Baltimore to take drug distributors to trial over opioids

CORRECTED-Baltimore to take drug distributors to trial over opioids Corrects headline and lead, adds paragraphs 4-5 to state that J&J settled before trial By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.
T
W
M

Walgreens paying $106.8 million to settle US prescription billing fraud charges

UPDATE 3-Walgreens paying $106.8 million to settle US prescription billing fraud charges Adds Justice Department comment, share price, paragraphs 4, 13 By Jonathan Stempel Sept 13 (Reuters) - Walgreens Boots Alliance WBA.O agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Friday.
W

CORRECTED Walgreens paying $106.8 million to settle US prescription billing fraud charges

CORRECTED (OFFICIAL)-UPDATE 2-Walgreens paying $106.8 million to settle US prescription billing fraud charges Corrects paragraph 3 to remove discussion of Walgreens reselling prescriptions and effectively being paid twice, after U.S. Department of Justice corrects press release to remove that accusation By Jonathan Stempel Sept 13 (Reuters) - Walgreens Boots Alliance WBA.O agreed to pay $106.8 million to settle charges it fraudulently billed the U.S.
W

Walgreens agrees to pay $106.8 mln to settle US charges over prescription billing

Walgreens agrees to pay $106.8 mln to settle US charges over prescription billing Sept 13 (Reuters) - Walgreens Boots Alliance WBA.O agreed to pay $106.8 million to settle charges it billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Friday. The Justice Department said that from 2009 to 2020, Walgreens submitted false claims for payment to Medicare, Medicaid and other federal health care programs for prescriptions it processed but which were
W

UK's Boots names Anthony Hemmerdinger as new boss

UK's Boots names Anthony Hemmerdinger as new boss LONDON, Sept 12 (Reuters) - British health and beauty retailer Boots has promoted Anthony Hemmerdinger to the managing director role, succeeding Seb James on Nov. 4, it said on Thursday. Boots UK, owned by U.S. listed Walgreens Boots Alliance WBA.O , is one of Britain's biggest retailers, trading from about 1,900 stores and employing 52,000. Hemmerdinger, a former Asda supermarket executive, has been Boots UK's retail and operations director sinc
W

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

UPDATE 1-Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial Adds comment from J&J in paragraph 6 By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.
T
W
M

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.
T
W
M

Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal

BUZZ-Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal ** Brokerage Jefferies cuts PT on drug distributor McKesson MCK.N to $607 from $630, while raising PT on peer Cardinal Health CAH.N to $110 from $105 ** Says despite MCK forecasting Q2 below estimates, co's reiteration of full-year forecast gives "some level of confidence" *
W
M

From Boeing to Detroit Three, US labor unions flex muscle

From Boeing to Detroit Three, US labor unions flex muscle Changes headline, recasts paragraph 1, adds Boeing labor deal in paragraph 14 By Mrinalika Roy Sept. 8 (Reuters) - U.S. planemaker Boeing .N> has averted a possible strike after reaching a tentative labor deal with a union representing more than 32,000 workers in the U.S. Pacific Northwest, the latest in a series of labor negotiations that brought double-digit wage increases despite a tight labor market and stubborn inflation.
B
J
S
V
W
U
A
U
W

Walgreens hit with lawsuit claiming generic cold medicine has cancer-causing chemical

Walgreens hit with lawsuit claiming generic cold medicine has cancer-causing chemical By Diana Novak Jones Sept 4 (Reuters) - Walgreens is facing a proposed class action lawsuit brought on Wednesday by customers who say they weren’t warned that the pharmacy chain’s generic version of cold medicine Mucinex contains a cancer-causing chemical. The lawsuit, filed in Chicago federal court, claims Walgreens did not label the products or otherwise warn customers that they contained benzene, a known
W

U.S. STOCKS Dyne Therapeutics, Maxeon Solar, chip stocks

BUZZ-U.S. STOCKS ON THE MOVE-Dyne Therapeutics, Maxeon Solar, chip stocks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell over 1% on Tuesday as investors assessed subdued factory activity data ahead of a slew of labor market reports due through the week that could influence the extent of monetary policy easing by the Federal Reserve.
B
C
C
G
I
M
N
N
R
T
W
A
U
R
U
U
U
S
T
X
I
M
M
R

Intel's Dow status under threat as struggling chipmaker's shares plunge

GRAPHIC-Intel's Dow status under threat as struggling chipmaker's shares plunge Updates shares in paragraph 3; Adds details on chip sales, analyst comment and background in paragraphs 8-10 By Arsheeya Bajwa Sept 3 (Reuters) - Intel was one of the first two tech companies to join the Dow Jones Industrial Average during the late-'90s dot-com boom, along with Microsoft.
A
I
M
N
U
W
T
U
U

U.S. STOCKS Walgreens, Copper miners, Simon Property

BUZZ-U.S. STOCKS ON THE MOVE-Walgreens, Copper miners, Simon Property Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell over 1% as investors assessed latest factory activity data, with a slew of labor market reports due through the week that could influence the extent of monetary policy easing by the Federal Reserve this year.
B
C
C
G
N
R
T
W
U
R
U
U
S
X
A
I
M
M
R

'Murky' path forward for Walgreens, Leerink Partners says

BUZZ-'Murky' path forward for Walgreens, Leerink Partners says Updates ** Brokerage Leerink Partners cuts PT on drugstore chain Walgreens Boots Alliance WBA.O to $9 from $11 ** Shares of Walgreens down 1.4% in early trading ** Company faces significantly higher interest expense in FY26 and FY27 and years of sales-leasebacks may complicate WBA's store closure plan, weighing on its cost-reduction efforts - brokerage ** WBA in June cut its FY24 profit forecast and said it would close underperformin
W

U.S. STOCKS Boeing, Southwest Airlines, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Southwest Airlines, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set for a lower open on Tuesday as investors moved to the sidelines ahead of a slew of economic data reports due through the week that could influence the extent of monetary policy easing by the Federal Reserve this year.
B
C
N
T
W
U
R
U
X
I
M

'Murky' path forward for Walgreens, Leerink Partners says

BUZZ-'Murky' path forward for Walgreens, Leerink Partners says ** Brokerage Leerink Partners cuts PT on drugstore chain Walgreens Boots Alliance WBA.O to $9 from $11 ** "More potential storm clouds loom on the horizon" for WBA, says brokerage ** Co faces significantly higher interest expense in FY26 and FY27 and years of sales-leasebacks may complicate the WBA's store closure plan, weighing on company's cost reduction efforts - brokerage ** WBA had cut its FY24 profit forecast and said it would
W

Intel's Dow status under threat as struggling chipmaker's shares plunge

GRAPHIC-Intel's Dow status under threat as struggling chipmaker's shares plunge By Arsheeya Bajwa Sept 3 (Reuters) - Intel was one of the first two tech companies to join the Dow Jones Industrial Average during 1999's dot-com era, along with Microsoft. Now, a slump in its share price could cost the American chipmaker its place in the blue-chip index.
A
I
M
N
W
T
U
U

U.S. Autodesk, Elastic NV, GMS

U.S. RESEARCH ROUNDUP-Autodesk, Elastic NV, GMS Aug 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Autodesk, Elastic NV and GMS, on Friday. HIGHLIGHTS * Autodesk Inc ADSK.O : RBC raises target price to $313 from $290 * Elastic NV ESTC.N : Piper Sandler cuts target price to $100 from $131 * GMS Inc GMS.N : Truist Securities cuts target price to $90 from $95 * Nvidia Corp NVDA.O : Baird raises target price to $150 f
A
G
M
N
N
W
C
D
U
D
S

U.S. STOCKS Lumen Technologies, Insulet, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 rose on Tuesday in mixed trading ahead of a highly anticipated quarterly report from Nvidia and economic data expected later in the week.
N
W
U
U
C
M
R



Kondisi

Aset Populer

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.